MEM
MEMPHASYS FPO [MEM]
Healthcare · ASX Small Cap
$0.0080 +0.0%
Updated 22 Jul 2026 · Signals refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Get alerts when MEM triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Trading above both moving averages — the trend is your friend here
- Beating the Small Ords index — relative strength of 1.40, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (0.6 quarters)
- 4C filed 2026-07-15
- Very high P/S ratio (115.4x)
- Revenue in sharp decline (-96%)
- Near 52-week high (91% of range)
- Small-cap ($20-100M)
- New substantial holder(s) (1)
- CANSLIM N: Near 52-week high (breakout territory)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 33% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (5.92%/day)
- Altman Z-Score grey zone (2.99, low-confidence approx)
- Penny stock risk ($0.008)
- RBA hiking (-3pts)
- Calendar: Quarterly 4C in 1d (+5pts)
Risk Signals
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -96% — the top line is shrinking
Ask Scout AI about MEM
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW Quarterly Activities/Appendix 4C Cash Flow Report
HIGH Becoming a substantial holder
NONE Memphasys Enters into Consulting Agreement with Director
NONE Exclusive Thailand Commercialisation Agreement Secured
NONE Section 708A Cleansing Statement
Recent ASX Announcements
| 2026-07-15 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-07-15 | Becoming a substantial holder |
| 2026-07-06 | Memphasys Enters into Consulting Agreement with Director |
| 2026-06-30 | Exclusive Thailand Commercialisation Agreement Secured PRICE SENSITIVE |
| 2026-06-26 | Section 708A Cleansing Statement |
Key Metrics
$24.7M
Market Cap
6.5M
Avg Volume
0.4x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
1 qtrs
Cash Runway
-87.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | pass | Near 52w High |
| S | Supply & Demand | neutral | Float: 53% |
| L | Leader vs Laggard | pass | RS: 30 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
101 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track MEM and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required